The Valley Desk

ArticlePharmaceuticals (Basel, Switzerland)Published

Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Pharmaceuticals (Basel, Switzerland)
Published
Subject terms
Reverse transcriptase; Human immunodeficiency virus; Reverse transcriptase inhibitor; Protease inhibitor; Alzheimer’s disease; Nucleoside Reverse Transcriptase Inhibitor; Somatic Gene Recombination
PubMed ID
38675371
PubMed Central ID
PMC11053431
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal